Results 201 to 210 of about 4,786,356 (294)
Schematic illustration of a biomimetic SKEV@AAV platform targeting p21‐high senescent Kupffer cells (sKCs) in hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT). p21‐high sKCs accumulate in the PVTT microenvironment and establish an immunosuppressive, SASP‐rich environment that facilitates tumor cell proliferation and immune evasion.
Na Ta +10 more
wiley +1 more source
The Dark Side of Antioxidants: When Scavenging ROS Undermines Plant Stress Acclimation. [PDF]
Qiu P, Chu Z, Xie Y.
europepmc +1 more source
Trypsinogen‐loaded nanoparticles reprogram TAMs via NF‐κB/NLRP3, driving M2→M1 conversion and potent phagocytosis to unleash antitumor immunity. ABSTRACT Although reprogramming tumor‐associated macrophages (TAMs) represents a promising therapeutic strategy, approaches that are both precise and safe remain scarce.
Lei Cao +7 more
wiley +1 more source
Regulatory T cells in autoimmune diseases: biological mechanisms, clinical translation, and translational challenges. [PDF]
Li J +6 more
europepmc +1 more source
LRRK2‐mutant induced pluripotent stem cells (iPSCs) were derived from a patient with Parkinson's disease (PD). Using CRISPR/Cas9–mediated gene editing, the pathogenic LRRK2 mutations were precisely corrected, and isogenic dopaminergic neural progenitor cells (DA‐NPCs) were subsequently generated.
Qing Yan +29 more
wiley +1 more source
Na/K-ATPase Signaling in Adipocytes Promotes Atherosclerosis. [PDF]
Goncalves BS +11 more
europepmc +1 more source
A Survey of Inducing Fault Tolerance in Software Systems with Stochastic Modelling Approach
openaire +1 more source
A biomimetic GOx/Arg‐loaded nanoplatform produces nitric oxide through an in situ catalytic cascade reaction, enabling dual‐target metabolic regulation in diabetes‐associated biofilm infections. Bacterial metabolism is disrupted, and macrophage immunometabolism is reprogrammed, resulting in biofilm eradication, immune restoration, and enhanced ...
Mingzhang Li +13 more
wiley +1 more source
TAR-0520, a new candidate in oncodermatology: Results of a phase 1 program in healthy volunteers. [PDF]
Andres P +3 more
europepmc +1 more source

